BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:fluticasone propionate readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of fluticasone propionate\, from ClinicalTri
 als.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07817134-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:fluticasone propionate: Phase 4 readout est. (NCT07817134)
DESCRIPTION:fluticasone propionate\, phase 4.\nStudy: A Study to Visualize 
 Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis\nEstimated
  primary completion: December 2026. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/fluticasone-propionate#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT07817134
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05535738-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:fluticasone propionate: Phase 2/3 readout est. (NCT05535738)
DESCRIPTION:fluticasone propionate\, phase 2/3.\nStudy: Using a Contact Der
 matitis Model With Biologic Medications to Study Skin Inflammation\nEstima
 ted primary completion: 1 January 2027. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/fluticasone-propionate#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT05535738
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07675252-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:fluticasone propionate: Phase 4 readout est. (NCT07675252)
DESCRIPTION:fluticasone propionate\, phase 4.\nStudy: Efficacy and Safety o
 f Fluticasone Propionate Nebulized Suspension for Wheezing Diseases in Inf
 ants Aged 0-24 Months\nEstimated primary completion: 31 May 2027. This is 
 a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can 
 move.\nDrug page: https://assetmemo.bio/drug/fluticasone-propionate#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT07675252
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05275686-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:fluticasone propionate: Phase 2 readout est. (NCT05275686)
DESCRIPTION:fluticasone propionate\, phase 2.\nStudy: Effect of Novel Exhal
 ational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysf
 unction (ETD)\nEstimated primary completion: 30 June 2027. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/fluticasone-propionate#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT05275686
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05922761-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:fluticasone propionate: Phase 2 readout est. (NCT05922761)
DESCRIPTION:fluticasone propionate\, phase 2.\nStudy: BElumosudil for Bronc
 hiolitis Obliterans Prevention/Therapy (BEBOP)\nEstimated primary completi
 on: 30 June 2027. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/flu
 ticasone-propionate#upcoming-events\nRegistry record: https://clinicaltria
 ls.gov/study/NCT05922761
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07664527-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:fluticasone propionate: Phase 4 readout est. (NCT07664527)
DESCRIPTION:fluticasone propionate\, phase 4\, Asthma.\nStudy: Novel Method
  for Removal of Orally Deposited Inhaled Fluticasone Propionate\nEstimated
  primary completion: September 2027. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/fluticasone-propionate#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT07664527
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07918404-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:fluticasone propionate: Phase 1 readout est. (NCT07918404)
DESCRIPTION:fluticasone propionate\, phase 1.\nStudy: Safety and Tolerabili
 ty of Fluticasone Propionate 10% Nasal Insert in Participants With Chronic
  Allergic Rhinitis\nEstimated primary completion: November 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/fluticasone-propionate#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07918404
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07582549-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:fluticasone propionate: Phase 3 readout est. (NCT07582549)
DESCRIPTION:fluticasone propionate\, phase 3.\nStudy: Finnish Children´s P
 rotracted Cough\nEstimated primary completion: December 2027. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/fluticasone-propionate#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07582549
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06234345-3789@assetmemo.bio
DTSTAMP:20261121T005720Z
DTSTART;VALUE=DATE:20280831
DTEND;VALUE=DATE:20280901
SUMMARY:fluticasone propionate: Phase 3 readout est. (NCT06234345)
DESCRIPTION:fluticasone propionate\, phase 3.\nStudy: Study of Fluticasone/
 Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary 
 Disease (TRIPLAR)\nEstimated primary completion: August 2028. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/fluticasone-propionate#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT06234345
URL:https://assetmemo.bio/drug/fluticasone-propionate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
